Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Standard Dose
10MG;12.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 078794 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 10MG;12.5MG Sponsor APOTEX Submission history Latest submission status date: 2024-08-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 078794 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 10MG;12.5MG Sponsor APOTEX Submission history Latest submission status date: 2024-08-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.